期刊文献+

低分子肝素治疗骨转移癌患者下肢深静脉血栓的疗效观察 被引量:6

暂未订购
导出
摘要 目的探讨低分子肝素(LMWH)治疗骨转移癌患者下肢深静脉血栓(DVT)的疗效和安全性。方法对51例骨转移癌合并DVT患者应用低分子肝素钠治疗,对其治疗前后的临床症状、体征、血小板(Plt)、部分凝血活酶时间(APTT)、D-二聚体(D-Dimer)进行比较。结果骨转移癌合并DVT患者治疗后DVT的总有效率为90.2%;治疗前后D-Dimer差异有统计学意义(P<0.01)。用药期间9例(17.6%)患者发生出血倾向,但无严重并发症。结论LMWH治疗骨转移癌合并DVT疗效确切,安全性较高。
出处 《山东医药》 CAS 2014年第25期61-62,共2页 Shandong Medical Journal
基金 河北省卫生厅资助项目(20130532)
  • 相关文献

参考文献14

  • 1Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes[ J]. Circulation, 2003,107 (23 Suppl 1 ) : 117-121.
  • 2Khorana AA, Francis CW, Culakova E, et al. Thromboembolism in hospitalized neutropenie cancer patients [ J ]. J Clin Oneol, 2006,24(3 ) :484-490.
  • 3Stein PD, Beemath A, Meyers FA, et al. Incidence of venous thromboembolism in patients hospitalized with cancer [ J]. Am J Med, 2006,119( 1 ) :60-68.
  • 4深静脉血栓形成的诊断和治疗指南(第2版)[J].中华外科杂志,2012,50(7):611-614. 被引量:509
  • 5Chew I-IK, Wun T, Harvey DJ, et al. Incidence of venous throm- boembolism and the impact on survival in breast cancer patients [J]. J Clin Oncol, 2007,25(1) :70-76.
  • 6齐加新,牟乐明,初向泉,高平,王伯珉,孙占胜.髋部骨折合并下肢深静脉血栓形成134例术前干预及结果分析[J].山东医药,2013,53(34):51-52. 被引量:8
  • 7Akl EA, Vasireddi SR, Gunukula S, et al. Anticoagulation for the initial treatment of venous thromboemholism in patients with cancer [ J]. Cochrane Database Syst Rev, 2011, (6) :CD006649.
  • 8van Doormaal FF, Raskob GE, Davidson BL, et al. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials [ J ]. Thmmb Haemost, 2009,101 (4) :762-769.
  • 9Niimi R, Hasegawa M, Sudo A, et al. Evaluation of soluble fibrin and D-dimer in the diagnosis of postoperative deep vein thrombosis [J]. Biomarkers, 2010,15(2) :149-157.
  • 10刘国辉,杨述华,杜靖远,郑启新,邵增务.纤溶酶治疗下肢深静脉血栓的疗效观察[J].临床外科杂志,2006,14(10):662-663. 被引量:7

二级参考文献37

  • 1栗剑,王福权,徐阳.骨折术后深静脉血栓的防治[J].中华创伤骨科杂志,2004,6(8):938-939. 被引量:36
  • 2刘国辉,杨述华,杜靖远,郑启新,邵增务.纤溶酶治疗下肢深静脉血栓的疗效观察[J].临床外科杂志,2006,14(10):662-663. 被引量:7
  • 3陈铖,曾跃林,谭屏,谭海涛,缪辉,宁晓颖.高龄患者髋部手术后深静脉血栓形成治疗分析[J].中华创伤骨科杂志,2006,8(11):1086-1087. 被引量:19
  • 4Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with maligenancy versus those without malignancy. Risk analysis using Medicare claims data[ J]. Medicine(Baltimore) , 1999,78 (5) :285-291.
  • 5Oudega R, Moons KG, Katel Nieuwenhuis H, et al. Deep vein thrombosis in primary care:possible malignancy? [J]. Br J Gen Pract, 2006,56 ( 530 ) : 693-696.
  • 6Hyers TM, Spyropoulos AC. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin [ J ]. J Thromb Thrombolysis, 2007,24 ( 3 ) :225-232.
  • 7Jeon YS, Yoon YH, Cho JY, et al. Catheter-directed thrombolysis with conventional aspiration thrombectomy for lower extremity deep vein thrombosis [ J ]. Yonsei Med J,2010,51 ( 2 ) : 197-201.
  • 8Kuderer NM, Khorana AA, Lyman GH, et al. A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications [J]. Cancer,2007,110(5) :1149-1161.
  • 9Theiss W,Wirtzfelc A,Fink U,et al.The success rate of fibrinolytic therapy in fresh and old thrombosis of the iliac and femoral veins[J].Angiology,1983,34(1):61-69.
  • 10Astedt B,Robertson B,Haeger K.Experience with standardized streptokinase therapy of deep venous thrombosis[J].J Surg Gynecol Obster,1974,139(3):387-388.

共引文献545

同被引文献50

引证文献6

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部